Where does OptiScan Biomedical Corporation rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), OptiScan Biomedical Corporation ranks #11,378 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does OptiScan Biomedical Corporation hold?

OptiScan Biomedical Corporation holds 27 US utility patents granted between 2015 and 2020, spanning 8 technology areas.

What is OptiScan Biomedical Corporation's Innovation Score?

OptiScan Biomedical Corporation has an Innovation Score of 34.5 out of 100 (48th percentile of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does OptiScan Biomedical Corporation focus on?

OptiScan Biomedical Corporation's top technology area is A61B (DIAGNOSIS; SURGERY; Identification) with 26 patents, ranking #709 of 7,127 assignees active in that subclass. Grants appear in 8 CPC subclasses total.

Is OptiScan Biomedical Corporation's patent grant rate increasing or decreasing?

OptiScan Biomedical Corporation's recent grant velocity is -83% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.

What does claim depth mean for OptiScan Biomedical Corporation's patents?

OptiScan Biomedical Corporation's patents average 21.6 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the OptiScan Biomedical Corporation patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

OptiScan Biomedical Corporation

USPTO PatentsView assignee record - 27 granted patents across 8 technology areas, recorded in grant years 2015–2020. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61B (DIAGNOSIS; SURGERY; Identification).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Optiscan ranks #11,378 of 49,997 tracked US assignees by granted-patent volume, with 27 patents across 8 technology areas.

#11,378
of 49,997 US assignees by volume: 48th percentile
by Innovation Score (34.5/100): 21.6
avg claims per patent: -83%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R11378 · US Corporation #11,378 · 27 grants

GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-DENSE · TYPE-USCORP · VEL-DROP · BOOK-FULL

GRANTS-SMALL 27 grants
UPPER-Q #11,378/49,997
PHOTO-FINISH Okta
CPC-NARROW A61B · 8 areas
INNOV-THIN 34.5/100
CLAIMS-DENSE 21.6 claims/avg
TYPE-USCORP US Corporation
VEL-DROP -83% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Okta, Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Optiscan’s 34.5 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 11.5 pts (33%) Velocity 0.0 pts (0%) Breadth 10.0 pts (29%) Claim depth 13.0 pts (38%)

Qualcomm Incorporated · highest

85
Aftershock Services · near

34
Cambro Manufacturing · near

34
Genesense Technology · near

34
OptiScan Biomedical · this assignee

34
TSI Products · near

34
3D Lighting… · lowest

7

What this shows Optiscan's Innovation Score is 34.5/100 (48th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Optiscan?

Each dot is one of Optiscan’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Optiscan’s own 21.6 claims/patent is ABOVE the 12.7 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Optiscan vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Optiscan's grants concentrate

OptiScan Biomedical Corporation is a focused PatentsView assignee: 8 CPC subclasses with 96.3% of grants classified under A61B (DIAGNOSIS; SURGERY; Identification). Peak complete grant year is 2018 (6 grants) versus a trough of 4 in 2015. By volume, Optiscan sits between Okta, Inc. and Pebble Technology, Inc..

Okta

27
Oldcastle Buildin…

27
Onepin

27
Onward Medical

27
Optumsoft

27
Pason Systems

27
Patlite

27
Pebble Technology

27
Optiscan Biomedic… ◀

27

What this shows OptiScan holds 27 patents at rank #11,378, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near OptiScan

By rank, the assignees closest to #11,378 in granted patent volume.

Leaders in A61B (Diagnosis)

Other assignees with the most granted patents in OptiScan's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for OptiScan, neither rank-band nor same-CPC leaders (those blocks stay above). In A61B (Diagnosis), OptiScan ranks #709 of 7,127 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (34 here).

TSI Products, Inc. 34 Aftershock Services, Inc. 34 Cambro Manufacturing Company 34 Genesense Technology Inc. 34

Optiscan's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

34 48th percentile higher than 48% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2020

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

OptiScan Biomedical Corporation patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	4	14.8%
2016	5	18.5%
2017	4	14.8%
2018	6	22.2%
2019	4	14.8%
2020	4	14.8%

Which technologies does OptiScan Biomedical Corporation patent most?

A61B - DIAGNOSIS; SURGERY; Identification 26

A61M - Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor 22

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 22

G16H - Healthcare Informatics, i.e. Information AND Communication Technology [ICT] Specially Adapted FOR THE Handling OR Processing OF Medical OR Healthcare Data 9

Y10T - Technical Subjects Covered BY Former US Classification 7

G16B - Bioinformatics, i.e. Information AND Communication Technology [ICT] Specially Adapted FOR Genetic OR Protein-related Data Processing IN Computational Molecular Biology 3

G16C - Computational CHEMISTRY; CHEMOINFORMATICS; Computational Materials Science 1

G01M - Testing Static OR Dynamic Balance OF Machines OR STRUCTURES; Testing OF Structures OR Apparatus, NOT Otherwise Provided FOR 1

Top 8 of 8 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

OptiScan Biomedical Corporation's patent record in context - here's where to go next.

OptiScan Biomedical Corporation's lead technology class is A61B (DIAGNOSIS; SURGERY; Identification), 96.3% of its portfolio - see every assignee active in that class. Explore A61B
Ranked #11,378 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare OptiScan Biomedical Corporation against Okta, Inc., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 34.5/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.